Search results

• Finished

  A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator's Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  Munker, R.

  IQVIA RDS Incorporated

  8/31/21 → 4/24/23

  Project: Research project

• An Open Label, Multi-Center Phase IIIb Study of Asciminib (ABL001) Monotherapy in Previously Treated Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

  Munker, R.

  Novartis (domestic)

  7/15/21 → 4/19/23

  Project: Research project

• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis

  Munker, R.

  Incyte Corporation

  5/13/21 → 4/24/23

  Project: Research project

• A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia (AML) (VIALE-T)

  Munker, R.

  AbbVie Incorporated

  6/10/20 → 5/12/21

  Project: Research project